Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer

R Thapa, O Afzal, G Gupta, AA Bhat, WH Almalki… - … -Research and Practice, 2023 - Elsevier
Breast cancer is a complex and diverse condition that disrupts multiple signaling pathways
essential for cell proliferation, survival, and differentiation. Recently, the significant …

[HTML][HTML] The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy

E Pavitra, J Kancharla, VK Gupta, K Prasad… - Biomedicine & …, 2023 - Elsevier
Breast cancer (BC) is the second most fatal disease and is the prime cause of cancer allied
female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated …

LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis

Y Wang, S Wu, X Zhu, L Zhang, J Deng, F Li… - Journal of Experimental …, 2019 - rupress.org
Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) with the most
aggressive phenotype and poor overall survival. Using bioinformatics tools, we identified …

[HTML][HTML] The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders

S Ghafouri-Fard, A Abak, F Fattahi, BM Hussen… - Biomedicine & …, 2021 - Elsevier
Nuclear factor-κB (NF-κB) represents a group of inducible transcription factors (TFs)
regulating the expression of a great variety of genes implicated in diverse processes …

LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1

X Deng, W Xiong, X Jiang, S Zhang, Z Li, Y Zhou… - Cell death & …, 2020 - nature.com
There is increasing evidence that long non-coding RNAs (lncRNAs) play important roles in
human tumorigenesis. By using publicly available expression profiling data from lung …

The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer

P Ye, L Feng, S Shi, C Dong - Cancers, 2022 - mdpi.com
Simple Summary Multidrug resistance (MDR) is a major cause of breast cancer (BC)
chemotherapy failure. Long noncoding RNAs (lncRNAs) have been shown closely related to …

Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer

E Amiri Souri, A Chenoweth, A Cheung… - British Journal of …, 2021 - nature.com
Background Prognostic stratification of breast cancers remains a challenge to improve
clinical decision making. We employ machine learning on breast cancer transcriptomics …

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer

S Li, C Shi, W Fu, J Zhang - Journal of Pharmacy and …, 2023 - academic.oup.com
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and
gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties …

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

F Hermida-Prado, Y Xie, S Sherman, Z Nagy, D Russo… - Cancer research, 2023 - AACR
Immunotherapies have yet to demonstrate significant efficacy in the treatment of hormone
receptor–positive (HR+) breast cancer. Given that endocrine therapy (ET) is the primary …

Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to …

D Kashyap, R Sharma, N Goel, HS Buttar… - Frontiers in …, 2023 - frontiersin.org
Dysregulation of epigenetic mechanisms have been depicted in several pathological
consequence such as cancer. Different modes of epigenetic regulation (DNA methylation …